(NASDAQ: IDXX) Idexx Laboratories's forecast annual revenue growth rate of 7.77% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.84%.
Idexx Laboratories's revenue in 2025 is $3,844,817,000.On average, 6 Wall Street analysts forecast IDXX's revenue for 2025 to be $336,169,954,663, with the lowest IDXX revenue forecast at $334,068,957,954, and the highest IDXX revenue forecast at $338,863,305,031. On average, 6 Wall Street analysts forecast IDXX's revenue for 2026 to be $364,564,116,982, with the lowest IDXX revenue forecast at $361,266,949,102, and the highest IDXX revenue forecast at $372,534,278,868.
In 2027, IDXX is forecast to generate $394,786,681,964 in revenue, with the lowest revenue forecast at $392,956,314,070 and the highest revenue forecast at $396,617,049,858.